Article Listing - FDA clears new indication for Abilify
STERLING WINTHROP
10 February 1992
Sterling Winthrop has named Christopher Coughlin as chief financial officer, succeeding George Benjamin, who has retired.
CYTOTHERAPEUTICS
10 February 1992
Thomas Wiggans has been named as chief operating officer of Cytotherapeutics.
ASTRA/T CELL SCIENCES DEAL
10 February 1992
Astra of Sweden and T Cell Sciences in the USA have concluded the agreement first set up last year (Marketletter...
UPJOHN'S HALCION
10 February 1992
Shareholders of the US pharmaceutical concern Upjohn (see also page 4) have filed a lawsuit which accuses the company's senior...
FRENCH HEALTH SPENDING SURPLUS
10 February 1992
The French social security budget is expecting to post a deficit of only 2 billion French francs ($364.3 million), this...
ROMANIAN MEDICINES TO RUSSIA
10 February 1992
Romania is to export unspecified quantities of medicines and drugs to the Russian Federation this year, following the signing of...
US APPROVAL FOR WELLCOME'S MIVACRON
10 February 1992
The US Food and Drug Administr-ation has granted marketing approval for Burroughs Wellcome's Mivacron (mivacurium chloride) to be used as...
OTC PRODUCTS IN EIRE
10 February 1992
The market for over-the-counter medicinal products in Ireland reached a value of almost IRL39 million ($65 million) last year. This...
FOURNIER PLANS GROWTH ABROAD
10 February 1992
French pharmaceutical group, Laboratoire Fournier, is planning foreign expansion following its failure to acquire Delagrange, which was finally acquired by...
CALCITRIOL BENEFIT FOR OSTEOPOROSIS
10 February 1992
Favorable results from a study involving Hoffmann-La Roche's calcitriol have been published by a New Zealand group led by Murray...
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
